Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer

NCT06233877 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: G-GLIP plus Mitomycin C

Sponsor

Hirschfeld Oncology